AbbVie Additional Paid In Capital from 2010 to 2025
| ABBV Stock | USD 205.29 2.57 1.27% |
Additional Paid In Capital | First Reported 2013-03-31 | Previous Quarter 20 B | Current Value 20.2 B | Quarterly Volatility 8.8 B |
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
AbbVie | Additional Paid In Capital |
Latest AbbVie's Additional Paid In Capital Growth Pattern
Below is the plot of the Additional Paid In Capital of AbbVie Inc over the last few years. Additional Paid In Capital (or APIC) is an accounting term found on AbbVie Inc Balance Sheet under Shareholders Equity. It is the value of the shares of the company above what they were issued it. The basic calculation is as follow: (Issue Price - Par Value) x AbbVie Shares Outstanding. Additional Paid In Capital is not affected by secondary trading of AbbVie Inc shares and does not have any impact on the value of APIC. It is the excess amount paid by investors over the par value of a company's shares, representing the additional capital contributed by shareholders. AbbVie's Additional Paid In Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
| Additional Paid In Capital | 10 Years Trend |
|
Additional Paid In Capital |
| Timeline |
AbbVie Additional Paid In Capital Regression Statistics
| Arithmetic Mean | 11,782,531,250 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 68.81 | |
| Mean Deviation | 6,839,832,031 | |
| Median | 14,756,000,000 | |
| Standard Deviation | 8,107,668,344 | |
| Sample Variance | 65734286T | |
| Range | 23.2B | |
| R-Value | 0.90 | |
| Mean Square Error | 12786117.3T | |
| R-Squared | 0.82 | |
| Slope | 1,540,634,559 | |
| Total Sum of Squares | 986014289.7T |
AbbVie Additional Paid In Capital History
About AbbVie Financial Statements
AbbVie investors use historical fundamental indicators, such as AbbVie's Additional Paid In Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Additional Paid In Capital | 23.2 B | 15 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AbbVie Stock Analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.